{Reference Type}: Journal Article
{Title}: Radiologically supervised bowel management program outcome in patients with chronic idiopathic constipation.
{Author}: Domínguez-Muñoz A;Bischoff A;Wehrli LA;Judd-Glossy L;Schneider L;Merritt A;Wickham M;Ketzer J;Rodriguez V;Peña A;De La Torre L;
{Journal}: Pediatr Surg Int
{Volume}: 39
{Issue}: 1
{Year}: 2023 Jul 10
{Factor}: 2.003
{DOI}: 10.1007/s00383-023-05508-9
{Abstract}: <B>OBJECTIVE: </B>This study aimed to analyze our radiologically supervised bowel management program (RS-BMP) outcomes in patients with chronic idiopathic constipation (CIC).<BR><B>METHODS: </B>A retrospective study was conducted. We included all patients with CIC who participated in our RS-BMP at Children´s Hospital Colorado from July 2016 to October 2022.<BR><B>RESULTS: </B>Eighty patients were included. The average time with constipation was 5.6 years. Before our RS-BMP, 95% had received non-radiologically supervised treatments, and 71% had attempted two or more treatments. Overall, 90% had tried Polyethylene Glycol and 43% Senna. Nine patients had a history of Botox injections. Five underwent anterograde continence procedure, and one a sigmoidectomy. Behavioral disorders (BD) were found in 23%. At the end of the RS-BMP, 96% of patients had successful outcomes, 73% were on Senna, and 27% were on enemas. Megarectum was detected in 93% of patients with successful outcomes and 100% with unsuccessful outcomes (p = 0.210). Of the patients with BD, 89% had successful outcomes, and 11% had unsuccessful.<BR><B>CONCLUSIONS: </B>Our RS-BMP has been proven to be effective in treating CIC. The radiologically supervised use of Senna and enemas was the appropriate treatment in 96% of the patients. BD and megarectum were associated with unsuccessful outcomes.